Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00565721 | A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis | completed | Phase 2 | 33 | GE HealthcareINDUSTRY | 1 | Aug 18, 2014 | clinicaltrials |
| NCT00338130 | Randomised Study to Compare the Efficacy of AZD6244 vs TMZ | completed | Phase 2 | 239 | AstraZenecaINDUSTRY | 10 | Aug 13, 2014 | clinicaltrials |
| NCT00710515 |
| Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies |
| completed |
| Phase 1 |
| 30 |
| AstraZenecaINDUSTRY |
| 2 |
| Aug 13, 2014 |
| clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00533702 | A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01859845 | Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma | completed | N/A | 63 | Northwestern UniversityOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00329641 | Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02203864 | Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma | completed | Phase 1 | 49 | Boehringer IngelheimINDUSTRY | 0 | Jul 31, 2014 | clinicaltrials |
| NCT00132704 | An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation | completed | — | 149 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01573494 | Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma | completed | N/A | 30 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jun 26, 2014 | clinicaltrials |
| NCT00920907 | Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma | completed | Phase 1 | 99 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00623766 | Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases | completed | Phase 2 | 99 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00003274 | Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery | completed | Phase 2 | 48 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00003339 | Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 48 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00025181 | Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00028431 | Novel Adjuvants for Peptide-Based Melanoma Vaccines | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00031733 | Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma | completed | Phase 2 | 60 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00085189 | Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma | completed | Phase 2 | 42 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00334776 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 6 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00669019 | Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00281957 | Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 109 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00816374 | Tailored Intervention for Melanoma Patient's Families | completed | N/A | 553 | Fox Chase Cancer CenterOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00436605 | Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00651157 | Viral Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 22, 2014 | clinicaltrials |
| NCT01339663 | Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00349206 | Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01014351 | Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | completed | Phase 2 | 70 | SCRI Development Innovations, LLCOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00356460 | Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma | completed | Phase 1 | 29 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00004135 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00184275 | Characterization of Brain Metastases | completed | — | 26 | Norwegian University of Science and TechnologyOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00084214 | STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma | completed | Phase 1 / Phase 2 | 103 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 6, 2014 | clinicaltrials |
| NCT02074605 | Cognitive Effects of Interferon in Patients With Melanoma | completed | — | 36 | University of ArizonaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT00631618 | Clinical Trial of Sutent to Treat Metastatic Melanoma | completed | Phase 2 | 12 | California Pacific Medical Center Research InstituteOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00313508 | Dendritic Cell Vaccination During Lymphoid Reconstruction | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 21, 2014 | clinicaltrials |
| NCT00012064 | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | completed | Phase 1 / Phase 2 | 56 | Lisata Therapeutics, Inc.INDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00672542 | Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells | completed | Phase 1 | 12 | Scott PruittOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00004196 | Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | completed | Phase 3 | 3,000 | University of Alabama at BirminghamOTHER | 1 | Jan 20, 2014 | clinicaltrials |
| NCT00436930 | Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | completed | Phase 2 | 200 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00462423 | Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study(AbraxAvast) | completed | Phase 2 | 50 | Lynn E. Spitler, MDOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00016263 | Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00796991 | Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine | completed | Phase 1 | 72 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01077050 | SciBase International Melanoma Pivotal Study | completed | N/A | 1,951 | SciBase ABOTHER | 2 | Dec 30, 2013 | clinicaltrials |
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | completed | Phase 3 | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00081042 | ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | completed | Phase 1 / Phase 2 | 50 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00598507 | Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma | completed | Phase 2 | 35 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00005875 | Nitrocamptothecin in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00007969 | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | QLT Inc.INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 18, 2014source: clinicaltrials